 | • レポートコード：MRC2106A374 • 出版社/出版日：Mordor Intelligence / 2021年5月30日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は、世界の骨髄穿刺濃縮液市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（システム、付属品）分析、用途別（整形手術、創傷治癒、末梢動脈疾患、血液がん、その他）分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の骨髄穿刺濃縮液市場規模：製品別（システム、付属品） ・世界の骨髄穿刺濃縮液市場規模：用途別（整形手術、創傷治癒、末梢動脈疾患、血液がん、その他） ・世界の骨髄穿刺濃縮液市場規模：地域別 ・競争状況 ・市場機会/将来の見通し |
The bone marrow aspirate concentrates market is expected to grow with a CAGR of 5.0%, during the forecast period. Bone marrow aspirate concentrate is made from the fluid which is taken from bone marrow. Bone marrow aspirate concentrate represents mononuclear cell concentration, red blood cell, immature myeloid precursors, granulocytes, and platelets which are derived through a minimally invasive procedure that avoids the risks of an open bone graft procedure and this cells can help in the healing of some bone and joint conditions.
Increased prevalence of orthopedic diseases and sports injuries, with high growth of the cosmetic surgery industry and increasing applications of the bone marrow aspirate concentrate (BMAC) products in the cosmetic and orthopedic surgeries, are driving the growth of the bone marrow aspirate concentrate market.
Furthermore, the new technological advancements, favorable government regulations and increasing prevalence of orthopedic diseases are the factors that may further contribute to the bone marrow aspirate concentrate market growth.
Key Market Trends
Orthopedic Surgery Segment is Expected to Hold a Significant Market Share
According to a collaborative survey, conducted by the United Nations and the World Health Organization (WHO), 80-90% people in China are suffering from osteoarthritis, of which more than 55% are aged 60 years or above.
According to the World Health Organization (WHO), around 9.6% of men and 18.0% of women aged over 60 years have symptomatic osteoarthritis in the world. Bone marrow-derived stem cell therapy is considered one of the promising and advanced treatments for osteoarthritis which reduces the injury healing time five to six weeks from four to six months in case of surgery. Hence with the increasing prevalence of osteoarthritis and rising preference for bone marrow-derived stem cell therapy uses are the key factors for the growth of the bone marrow aspirate concentrates market.
North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major share globally in the bone marrow aspirate concentrates market due to rising prevalence of osteoarthritis diseases, rise in technological advancements, and awareness about stem cell therapy in this region.
Osteoarthritis (OA) is the most common joint disorder in the United States which occurs in 10% men and 13% in women aged 60 years or older. According to The Osteoarthritis Research Society International by the year 2030, an estimated 67 million adults aged 18 years and older will have doctor-diagnosed osteoarthritis. Furthermore, the increasing incidence of osteoarthritis diseases and a growing geriatric population in the country is fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The Bone Marrow Aspirate Concentrates Market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some players are adopting numerous strategies including acquisitions and collaborations to sustain competitive advantage.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Orthopedic Diseases and Sports Injuries
4.2.2 Rise in Healthcare Expenditure
4.3 Market Restraints
4.3.1 High Failure Rate
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Bone Marrow Aspirate Concentrates Systems
5.1.2 Bone Marrow Aspirate Concentrates Accessories
5.2 By Application
5.2.1 Orthopedic Surgery
5.2.2 Wound Healing
5.2.3 Peripheral Vascular Disease
5.2.4 Blood Cancer
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Arthrex, Inc
6.1.2 Aspire Medical Innovation
6.1.3 ThermoGenesis Corp.
6.1.4 EmCyte Corporation
6.1.5 Globus Medical, Inc
6.1.6 MED & CARE Innovative Solutions
6.1.7 Stryker Corporation
6.1.8 Ranfac Corporation
6.1.9 Terumo BCT
6.1.10 Zimmer Biomet Holdings, Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS